2027 ICD-10-CM Diagnosis Code D07.39Carcinoma in situ of other female genital organs
ICD-10-CM Codes›C00–D49›D00-D09›D07
- Billable — Valid for Submission
- Chronic Condition
D07.39 is a billable ICD-10-CM diagnosis code for carcinoma in situ of other female genital organs. It is valid on HIPAA claims for fiscal year 2027 (October 1, 2026 through September 30, 2027) and groups to MS-DRG 731 through 733, 754 through 756. Coders also document this condition as carcinoma in situ of broad ligament. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Female reproductive system cancers - all other types.
Code Identity
Code Classification
Approximate SynonymsGuidance
Alternate terms and clinical phrases that map to this code.
- Carcinoma in situ of broad ligament
- Carcinoma in situ of fallopian tube
- Carcinoma in situ of ovary
- Carcinoma in situ of parametrium
- Carcinoma in situ of round ligament of uterus
- Carcinoma in situ of uterine adnexa
- Neoplasm of parametrium
- Neoplasm of round ligament of uterus
Instructional NotesGuidance
Instructions from the official ICD-10-CM Tabular List that apply to D07.39: its own notes plus those printed at D07, block D00-D09, and Chapter 2. A note printed at a category, block or chapter applies to every code under it.
Includes
Further defines, or gives examples of, the content of the category.
- Bowen's disease
- erythroplasia
- grade III intraepithelial neoplasia
- Queyrat's erythroplasia
Excludes1
Not coded here: the excluded code is never reported together with this one, unless the two conditions are unrelated.
Notes
General instructions on how these codes are used.
- Functional activity
- All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
- Morphology [Histology]
- Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
- Primary malignant neoplasms overlapping site boundaries
- A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
- Malignant neoplasm of ectopic tissue
- Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
Source: CMS ICD-10-CM Tabular List. How to read instructional notes.
Referenced in Other NotesGuidance
Instructional notes printed at other codes that name D07.39, its category, or a range that includes it.
Applicable To 1
These notes mention D07.39.
Excludes1 3
These codes carry an Excludes1 note naming D07.39: they are not reported together with it, unless the two conditions are unrelated.
- D09.3 Carcinoma in situ of thyroid and other endocrine glandscarcinoma in situ of ovary (D07.39)
- D04.5 Carcinoma in situ of skin of trunkcarcinoma in situ of skin of genital organs (D07.-) names D07.-, which includes this code
- R87.7 Abnormal histological findings in specimens from female genital organs
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Table of NeoplasmsClinical
Anatomical sites in the Table of Neoplasms that reference this code family.
| Site | Malig. Primary | Malig. Secondary | Ca in situ | Benign | Uncertain | Unspec. |
|---|---|---|---|---|---|---|
| adnexa (uterine) | C57.4 | C79.89 | D07.39 | D28.7 | D39.8 | D49.59 |
| broad ligament | C57.1 | C79.82 | D07.39 | D28.2 | D39.8 | D49.59 |
| corpus › albicans | C56. | C79.6 | D07.39 | D27. | D39.1 | D49.59 |
| fallopian tube (accessory) | C57.0 | C79.82 | D07.39 | D28.2 | D39.8 | D49.59 |
| genital organ or tract › female NEC › specified site NEC | C57.7 | C79.82 | D07.39 | D28.7 | D39.8 | D49.59 |
| ligament [See Also: Neoplasm, connective tissue] › broad | C57.1 | C79.82 | D07.39 | D28.2 | D39.8 | D49.59 |
| ligament [See Also: Neoplasm, connective tissue] › Mackenrodt's | C57.7 | C79.82 | D07.39 | D28.7 | D39.8 | D49.59 |
| ligament [See Also: Neoplasm, connective tissue] › utero-ovarian | C57.7 | C79.82 | D07.39 | D28.2 | D39.8 | D49.59 |
| Mackenrodt's ligament | C57.7 | C79.82 | D07.39 | D28.7 | D39.8 | D49.59 |
| mesosalpinx | C57.1 | C79.82 | D07.39 | D28.2 | D39.8 | D49.59 |
| mesovarium | C57.1 | C79.82 | D07.39 | D28.2 | D39.8 | D49.59 |
| Mullerian duct › female | C57.7 | C79.82 | D07.39 | D28.7 | D39.8 | D49.59 |
| ovary | C56. | C79.6 | D07.39 | D27. | D39.1 | D49.59 |
| oviduct | C57.0 | C79.82 | D07.39 | D28.2 | D39.8 | D49.59 |
| paroophoron | C57.1 | C79.82 | D07.39 | D28.2 | D39.8 | D49.59 |
| parovarium | C57.1 | C79.82 | D07.39 | D28.2 | D39.8 | D49.59 |
| salpinx (uterine) | C57.0 | C79.82 | D07.39 | D28.2 | D39.8 | D49.59 |
| tubo-ovarian | C57.8 | C79.82 | D07.39 | D28.7 | D39.8 | D49.59 |
| utero-ovarian | C57.8 | C79.82 | D07.39 | D28.7 | D39.8 | D49.59 |
| utero-ovarian › ligament | C57.1 | C79.82 | D07.39 | D28.2 | D39.8 | D49.59 |
| uterus, uteri, uterine › adnexa NEC | C57.4 | C79.82 | D07.39 | D28.7 | D39.8 | D49.59 |
| uterus, uteri, uterine › ligament › broad | C57.1 | C79.82 | D07.39 | D28.2 | D39.8 | D49.59 |
| uterus, uteri, uterine › tube | C57.0 | C79.82 | D07.39 | D28.2 | D39.8 | D49.59 |
| wolffian (body) (duct) › female | C57.7 | C79.82 | D07.39 | D28.7 | D39.8 | D49.59 |
Patient EducationClinical
Cancer
Cancer is not just one disease but many diseases. Cancer begins in your cells, which are the building blocks of your body. Usually, your body forms new cells as needed, replacing old cells that die. Sometimes this process goes wrong. New cells grow even when you don't need them, and old cells don't die when they should.
The full article covers:
- What is cancer?
- What are the types of cancer?
- How does cancer develop?
- What are the symptoms of cancer?
- How is cancer diagnosed?
- What are the treatments for cancer?
- Can cancer be prevented?
Read the full article at MedlinePlus
Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.
Convert D07.39 to ICD-9-CMHistory
The closest ICD-9-CM equivalents under the General Equivalence Mappings.
Code HistoryHistory
Questions About D07.39Overview
What is the ICD-10 code for carcinoma in situ of other female genital organs?
The ICD-10-CM code for carcinoma in situ of other female genital organs is D07.39 (sometimes written as D0739). It is billable on HIPAA-covered claims from October 1, 2026 through September 30, 2027.
Is D07.39 a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report carcinoma in situ of other female genital organs on HIPAA-covered claims from October 1, 2026 through September 30, 2027.
What MS-DRG does D07.39 group to?
When carcinoma in situ of other female genital organs is the principal diagnosis on an inpatient stay, it groups to MS-DRG 732, 755, 756, 754, 733, 731, with relative weights from 0.8583 to 3.5462 depending on complications. Higher weights mean higher Medicare reimbursement.
Can D07.39 be reported with D03.5?
Not as a rule. The Excludes1 note at D07, which applies to D07.39, lists "melanoma in situ of trunk (D03.5)". An Excludes1 note means the excluded code is never reported together with this one; the only exception is when the two conditions are unrelated to each other (Official Guidelines, Section I.A.12.a).
What is the ICD-9 equivalent of D07.39?
Under the General Equivalence Mappings, carcinoma in situ of other female genital organs converts to ICD-9-CM 233.39 (ca in situ fem gen NEC). The mapping is approximate, so confirm the match fits the documentation.
